Pharmaceutical composition comprising sophorolipid in combination with an antibiotic
US-2015094273-A1 · Apr 2, 2015 · US
US10155043B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10155043-B2 |
| Application number | US-201615388615-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 22, 2016 |
| Priority date | Dec 29, 2015 |
| Publication date | Dec 18, 2018 |
| Grant date | Dec 18, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A composition comprising a bitter tastant and at least one sophorolipid and optionally a carrier; wherein the composition is edible and wherein the bitter taste of said bitter tastant is reduced. A method of reducing bitter taste attributed to a bitter tastant in an edible composition, said method comprising adding to said edible composition an effective amount of at least one sophorolipid and optionally a carrier; such that any bitter taste induced by the bitter tastant is reduced.
Opening claim text (preview).
We claim: 1. A method of inhibiting or reducing the bitter taste due to a bitter tastant, wherein the method comprises placing in the oral cavity of a subject an effective amount of a composition comprising at least one sophorolipid and optionally a carrier; wherein said sophorolipid is selected from the group consisting of C16-SL, C18-SL, C18:1-SL, and mixtures thereof. 2. A method of reducing bitter taste attributed to a bitter tastant in an edible composition, said method comprising adding to said edible composition an effective amount of at least one sophorolipid and optionally a carrier; such that any bitter taste induced by the bitter tastant is reduced; wherein said sophorolipid is selected from the group consisting of C16-SL, C18-SL, C18:1-SL, and mixtures thereof. 3. A method of inhibiting, reducing, or eliminating a bitter taste in a subject, said method comprising placing in the oral cavity of the subject an effective amount of at least one sophorolipid and optionally a carrier; wherein said sophorolipid is selected from the group consisting of C16-SL, C18-SL, C18:1-SL, and mixtures thereof. 4. A method of inhibiting a bitter taste receptor, said method comprising contacting the bitter taste receptor with a composition comprising an effective amount of at least one sophorolipid and optionally a carrier; wherein said sophorolipid is selected from the group consisting of C16-SL, C18-SL, C18:1-SL, and mixtures thereof. 5. The method according to claim 1 , wherein said sophorolipid is C18:1-SL. 6. The method according to claim 2 , wherein said sophorolipid is C18:1-SL. 7. The method according to claim 3 , wherein said sophorolipid is C18:1-SL. 8. The method according to claim 4 , wherein said sophorolipid is C18:1-SL. 9. The method of claim 2 , wherein said edible composition is a food product. 10. The method of claim 9 , wherein said sophorolipid is C18:1-SL.
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Fatty acids; Fats; Products containing oils or fats · CPC title
Addition of bitterness inhibitors · CPC title
Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin · CPC title
using additives (addition of substantially indigestible substances A23L33/21) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.